Elsevier

The Lancet

Volume 356, Issue 9240, 28 October 2000, Pages 1494-1495
The Lancet

Research Letters
Onset of coeliac disease during treatment with interferon for chronic hepatitis C

https://doi.org/10.1016/S0140-6736(00)02880-4Get rights and content

Summary

The immunomodulatory properties of interferon may concur to precipitate or worsen an underlying autoimmune disorders. We report the cases of two men who displayed the various features of coeliac disease during a treatment with α-interferon (in one case associated with ribavirin) for chronic hepatitis C. The patients stopped the interferon treatment and the symptoms and histological disorders improved after a gluten-free diet. α-interferon is available wordwide for treatment of chronic viral hepatitis. Before treatment with this drug, the patients would have to be monitored for coeliac disease.

References (4)

There are more references available in the full text version of this article.

Cited by (0)

View full text